Dementia, Mild
53
10
14
26
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.8%
2 terminated out of 53 trials
92.9%
+6.3% vs benchmark
6%
3 trials in Phase 3/4
15%
4 of 26 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 26 completed trials
Clinical Trials (53)
The "Let's Talk Tech" Tool to Support Decision Making About Technology Use
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Adaptation of the Uniform Data Set for Telematic Administration
Autonomic Involvement in Patient With Cognitive Decline
Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)
Pain With Dementia
Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease
FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease
The Brain Health Champion Study
Decision Making Tool for Firearm Storage
Identify the Benefits CAREGIVERSPRO-MMD Platform Use Based on the Information and Communications Technology, Dedicated to the Support and Assistance of Dyads Living With Neurocognitive Diseases and Their Primary Caregivers
Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial
Development of Pressure Sensor Based Dementia and Fall Prevention Program for Older Adults
Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment
Cognitive Screening Made Easy for PCPs - Administrative Supplement
Cognitive Screening Made Easy for PCPs - R33 Phase
Family Caregiver Online Survey (Dementia and Swallowing Difficulties)
Event-Related Potential (ERP) Components in Clinical Diagnosis
Tau PET Outcomes With Anti-amyloid Immunotherapies
Buddy-Up Dyadic Physical Activity Program for Persons With Dementia and Family Caregivers